Abstract
Crigler-Najjar (CN) disease is caused by a deficiency of the hepatic enzyme, bilirubin UDP-glucuronosyltransferase (B-UGT). We have found two CN type II patients, who were homozygous for a leucine to arginine transition at position 15 of B-UGT1. This mutation is expected to disrupt the hydrophobic core of the signal peptide of B-UGT1. Wild type and mutant B-UGT cDNAs were transfected in COS cells. Mutant and wild type mRNA were formed in equal amounts. The mutant protein was expressed with 0.5% efficiency, as compared to wild type. Mutant and wild type mRNAs were translated in vitro. Wild type transferase is processed by microsomes, no processing of the mutant protein was observed.
MeSH terms
-
Amino Acid Sequence
-
Animals
-
Base Sequence
-
Cell Line
-
Crigler-Najjar Syndrome / enzymology
-
Crigler-Najjar Syndrome / genetics*
-
Endoplasmic Reticulum / enzymology*
-
Gene Expression
-
Genes, Recessive
-
Glucuronosyltransferase / chemistry
-
Glucuronosyltransferase / genetics*
-
Glucuronosyltransferase / metabolism
-
Homozygote
-
Humans
-
Hyperbilirubinemia / enzymology
-
Hyperbilirubinemia / genetics
-
Liver / enzymology*
-
Molecular Sequence Data
-
Point Mutation
-
Protein Biosynthesis
-
Protein Sorting Signals / chemistry
-
Protein Sorting Signals / genetics*
-
Recombinant Proteins / genetics
-
Recombinant Proteins / metabolism
-
Sequence Analysis
-
Transcription, Genetic
-
Transfection
Substances
-
Protein Sorting Signals
-
Recombinant Proteins
-
Glucuronosyltransferase